Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
The Medical Journal of Australia
|
May 14, 2026
Primary Hyperparathyroidism in Adults: Recent Developments in Diagnosis and Management
Elizabeth Wootton, Sunita M C De Sousa, Richard L Prince, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 29, 2016
High clinical and morphologic response using <sup>90</sup>Y-DOTA-octreotate sequenced with <sup>177</sup>Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours
Grace Kong, Jason Callahan, Michael S Hofman, et al.
Advances in Urology
|
August 30, 2021
Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic Review
Stephen McGeorge, Michael Kwok, Andrew Jiang, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
August 19, 2016
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
Chian A Chang, David A Pattison, Richard W Tothill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2025
A Method for Validating PET and SPECT Cameras for Quantitative Clinical Imaging Trials Using Novel Radionuclides
Dale L Bailey, Kathy P Willowson, Graeme O'Keefe, et al.
EJNMMI Research
|
December 20, 2021
Risk of metastatic disease using [<sup>18</sup>F]PSMA-1007 PET/CT for primary prostate cancer staging
Venkata Avinash Chikatamarla, Satomi Okano, Peter Jenvey, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 23, 2019
Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol
Amir Iravani, Benjamin Solomon, David A Pattison, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 13, 2017
Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma
Grace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 16, 2023
Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI
Evyn G Arnfield, Laura Tam, David A Pattison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2022
The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
Sze Ting Lee, Louise M Emmett, David A Pattison, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
The Medical Journal of Australia
|
May 14, 2026
Primary Hyperparathyroidism in Adults: Recent Developments in Diagnosis and Management
Elizabeth Wootton, Sunita M C De Sousa, Richard L Prince, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 29, 2016
High clinical and morphologic response using <sup>90</sup>Y-DOTA-octreotate sequenced with <sup>177</sup>Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours
Grace Kong, Jason Callahan, Michael S Hofman, et al.
Advances in Urology
|
August 30, 2021
Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic Review
Stephen McGeorge, Michael Kwok, Andrew Jiang, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
August 19, 2016
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
Chian A Chang, David A Pattison, Richard W Tothill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2025
A Method for Validating PET and SPECT Cameras for Quantitative Clinical Imaging Trials Using Novel Radionuclides
Dale L Bailey, Kathy P Willowson, Graeme O'Keefe, et al.
EJNMMI Research
|
December 20, 2021
Risk of metastatic disease using [<sup>18</sup>F]PSMA-1007 PET/CT for primary prostate cancer staging
Venkata Avinash Chikatamarla, Satomi Okano, Peter Jenvey, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 23, 2019
Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol
Amir Iravani, Benjamin Solomon, David A Pattison, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 13, 2017
Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma
Grace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 16, 2023
Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI
Evyn G Arnfield, Laura Tam, David A Pattison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2022
The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
Sze Ting Lee, Louise M Emmett, David A Pattison, et al.
Page
of 8